Advertisement
Screener

CVS HEALTH CORPORATION (CVS) Scorecard

2.8 / 5 stars · 68/120 Roast Me

CVS HEALTH CORPORATION (CVS) Scorecard

  • 2026-Q2: Total return Win; Revenue growth Lose; EPS growth Lose.
  • 2026-Q1: Total return Lose; Revenue growth Lose; EPS growth Lose.
  • 2025-Q4: Total return Win; Revenue growth Lose; EPS growth Lose.
  • 2025-Q3: Total return Win; Revenue growth Win; EPS growth Lose.
40 QUARTERS × 3 ROAST BATTLES
55/120 All 120 Win/Lose results shown below

Every strict quarterly win earns 1 point. A loss, tie, or unavailable scoring value earns 0.

Trailing 1 year (4 quarters): 4 wins, 8 lossesLast fetched: 4 Sept 2026

Complete point ledger

Each cell identifies the missing side explicitly.

QuarterTotal returnRevenue growthEPS growth
2026-Q21/3 WinCVS / S&P
45.30% / 15.20% 		LoseCVS / S&P
7.36% / 15.00% 		LoseCVS / S&P
5.85% / 50.40%
2026-Q10/3 LoseCVS / S&P
-8.76% / -4.33% 		LoseCVS / S&P
7.64% / 11.30% 		LoseCVS / S&P
-45.48% / 27.70%
2025-Q41/3 WinCVS / S&P
6.13% / 2.65% 		LoseCVS / S&P
7.85% / 9.00% 		LoseCVS / S&P
-61.85% / 13.40%
2025-Q32/3 WinCVS / S&P
10.48% / 8.12% 		WinCVS / S&P
6.82% / 4.61% 		LoseCVS / S&P
-90.13% / 13.45%
2025-Q21/3 LoseCVS / S&P
2.87% / 10.94% 		WinCVS / S&P
6.44% / 4.83% 		LoseCVS / S&P
-36.23% / 10.63%
2025-Q12/3 WinCVS / S&P
52.84% / -4.27% 		WinCVS / S&P
4.99% / 4.98% 		LoseCVS / S&P
-26.32% / 10.57%
2024-Q40/3 LoseCVS / S&P
-27.81% / 2.41% 		LoseCVS / S&P
4.20% / 5.25% 		LoseCVS / S&P
-43.28% / 6.15%
2024-Q32/3 WinCVS / S&P
7.67% / 5.89% 		WinCVS / S&P
6.07% / 5.89% 		LoseCVS / S&P
-40.60% / 6.11%
2024-Q22/3 LoseCVS / S&P
-25.24% / 4.28% 		WinCVS / S&P
7.09% / 5.38% 		WinCVS / S&P
143.72% / 5.12%
2024-Q12/3 LoseCVS / S&P
1.93% / 10.56% 		WinCVS / S&P
9.07% / 5.71% 		WinCVS / S&P
82.69% / 5.59%
2023-Q43/3 WinCVS / S&P
14.06% / 11.69% 		WinCVS / S&P
10.95% / 6.81% 		WinCVS / S&P
99.69% / 7.78%
2023-Q33/3 WinCVS / S&P
1.83% / -3.27% 		WinCVS / S&P
10.34% / 7.52% 		WinCVS / S&P
164.94% / -5.03%
2023-Q21/3 LoseCVS / S&P
-6.21% / 8.74% 		WinCVS / S&P
10.18% / 9.50% 		LoseCVS / S&P
-63.33% / -8.57%
2023-Q10/3 LoseCVS / S&P
-19.71% / 7.50% 		LoseCVS / S&P
10.37% / 10.77% 		LoseCVS / S&P
-48.94% / -15.69%
2022-Q40/3 LoseCVS / S&P
-1.70% / 7.56% 		LoseCVS / S&P
10.39% / 11.88% 		LoseCVS / S&P
-46.18% / -17.99%
2022-Q31/3 WinCVS / S&P
3.52% / -4.88% 		LoseCVS / S&P
10.58% / 13.47% 		LoseCVS / S&P
-56.12% / -1.41%
2022-Q22/3 WinCVS / S&P
-7.97% / -16.10% 		LoseCVS / S&P
10.61% / 13.71% 		WinCVS / S&P
15.60% / 11.04%
2022-Q11/3 WinCVS / S&P
-1.37% / -4.60% 		LoseCVS / S&P
10.62% / 15.97% 		LoseCVS / S&P
8.91% / 42.23%
2021-Q41/3 WinCVS / S&P
22.27% / 11.03% 		LoseCVS / S&P
8.71% / 15.00% 		LoseCVS / S&P
10.26% / 96.40%
2021-Q31/3 WinCVS / S&P
2.32% / 0.58% 		LoseCVS / S&P
6.83% / 10.77% 		LoseCVS / S&P
-5.45% / 69.42%
2021-Q21/3 WinCVS / S&P
11.64% / 8.55% 		LoseCVS / S&P
5.29% / 6.58% 		LoseCVS / S&P
-13.35% / 51.81%
2021-Q12/3 WinCVS / S&P
10.88% / 6.17% 		WinCVS / S&P
3.40% / -1.06% 		LoseCVS / S&P
1.63% / 7.39%
2020-Q43/3 WinCVS / S&P
17.94% / 12.15% 		WinCVS / S&P
4.65% / -3.72% 		WinCVS / S&P
7.48% / -33.42%
2020-Q32/3 LoseCVS / S&P
-9.41% / 8.93% 		WinCVS / S&P
9.66% / -2.04% 		WinCVS / S&P
80.60% / -27.10%
2020-Q22/3 LoseCVS / S&P
10.42% / 20.54% 		WinCVS / S&P
16.94% / -0.46% 		WinCVS / S&P
77.68% / -27.11%
2020-Q11/3 LoseCVS / S&P
-19.60% / -19.60% 		WinCVS / S&P
25.05% / 3.47% 		LoseCVS / S&P
-1274.47% / -14.75%
2019-Q42/3 WinCVS / S&P
18.68% / 9.07% 		WinCVS / S&P
32.41% / 5.36% 		LoseCVS / S&P
-975.86% / 2.99%
2019-Q33/3 WinCVS / S&P
16.78% / 1.70% 		WinCVS / S&P
29.39% / 5.02% 		WinCVS / S&P
10.93% / 0.21%
2019-Q22/3 LoseCVS / S&P
2.01% / 4.30% 		WinCVS / S&P
20.91% / 6.64% 		WinCVS / S&P
21.23% / 8.65%
2019-Q11/3 LoseCVS / S&P
-17.06% / 13.65% 		WinCVS / S&P
12.73% / 8.12% 		LoseCVS / S&P
-107.22% / 14.29%
2018-Q40/3 LoseCVS / S&P
-16.19% / -13.52% 		LoseCVS / S&P
4.95% / 9.05% 		LoseCVS / S&P
-108.99% / 18.23%
2018-Q31/3 WinCVS / S&P
23.26% / 7.71% 		LoseCVS / S&P
3.13% / 10.21% 		LoseCVS / S&P
-37.47% / 19.06%
2018-Q21/3 WinCVS / S&P
4.23% / 3.43% 		LoseCVS / S&P
3.42% / 9.03% 		LoseCVS / S&P
-41.60% / 14.46%
2018-Q11/3 LoseCVS / S&P
-13.66% / -0.76% 		LoseCVS / S&P
3.98% / 7.68% 		WinCVS / S&P
35.91% / 12.46%
2017-Q41/3 LoseCVS / S&P
-10.26% / 6.64% 		LoseCVS / S&P
4.08% / 7.03% 		WinCVS / S&P
31.36% / 13.82%
2017-Q30/3 LoseCVS / S&P
1.73% / 4.48% 		LoseCVS / S&P
5.59% / 5.68% 		LoseCVS / S&P
3.43% / 17.57%
2017-Q22/3 WinCVS / S&P
3.16% / 3.09% 		WinCVS / S&P
8.43% / 4.83% 		LoseCVS / S&P
14.94% / 17.74%
2017-Q11/3 LoseCVS / S&P
0.08% / 6.07% 		WinCVS / S&P
11.64% / 3.67% 		LoseCVS / S&P
3.90% / 13.32%
2016-Q41/3 LoseCVS / S&P
-10.89% / 3.82% 		WinCVS / S&P
15.81% / 2.09% 		LoseCVS / S&P
5.82% / 7.05%
2016-Q32/3 LoseCVS / S&P
-6.64% / 3.85% 		WinCVS / S&P
15.75% / 0.20% 		WinCVS / S&P
5.18% / -3.15%

Dividend-reinvested, split-adjusted total return

1Y · 2025-08-29 to 2026-08-27

MetricCVS total returnS&P 500 Total Return Index
Total return31.06%20.78%
Annualized return31.06%20.78%

5Y · 2021-09-01 to 2026-08-27

MetricCVS total returnS&P 500 Total Return Index
Total return27.97%83.14%
Annualized return5.06%12.86%

10Y · 2016-09-01 to 2026-08-27

MetricCVS total returnS&P 500 Total Return Index
Total return35.50%319.30%
Annualized return3.09%15.41%

Calculation rules

window
Latest 40 completed benchmark quarters; unavailable issuer evidence remains visible and scores 0.
return Basis
Issuer adjusted close reinvests distributions and normalizes splits; the S&P 500 Total Return Index is the direct benchmark.
point Rule
Strict same-quarter win = 1. Loss, tie or unavailable evidence = 0. No partial or subjective points.
frequency
Quarter endpoints only.
fundamentals
Trailing-four-quarter issuer revenue and EPS growth use the issuer's normalized government-filed facts.
non Scoring

Snapshot captured 2026-09-04.

Similar stocks

Stock NameCountryMarket CapPE Ratio
PETMED EXPRESS INC (PETS)United States$0.034B-1.41
Advertisement